GILD vs MLSS · P/E 18, rev $29.44B vs $29.9M cap
Gilead Sciences Inc (GILD) versus Milestone Scientific (MLSS) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Milestone Scientific (MLSS) is a medical instruments & supplies company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
MLSS does not have a complete income-statement cache yet.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MLSS currently screens at market cap $29.9M.
Not investment advice. Open the GILD and MLSS stock pages for the full models.
Not investment advice.